Concepedia

Matthew P. Bourbeau

MP

Statistics

Publications

22

Citations

985

H-Index

18

Active since

2001

Affiliations

Amgen (United States)(Current)

University of Virginia

Université Bourgogne Franche-Comté

McCormick (United States)

Broad Institute

Matthew P. Bourbeau is an author at Amgen (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2001–2025

22

Publications

22

Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2−Tumor Protein 53 Protein−Protein Interaction

John G. Allen, Matthew P. Bourbeau, G. Erich Wohlhieter et al. · Journal of Medicinal Chemistry · 2009 · 147 citations · Full text

Medicine, Oncology, Pharmacology +13

Synthesis of Enantioenriched Propargylic Alcohols Related to Polyketide Natural Products. A Comparison of Methodologies

James A. Marshall, Matthew P. Bourbeau · Organic Letters · 2003 · 96 citations

Natural Sciences, Chemistry, Catalysis +14

Total Synthesis of (−)-Callystatin A

James A. Marshall, Matthew P. Bourbeau · The Journal of Organic Chemistry · 2001 · 91 citations

Pharmacy, Medicinal Chemistry, Combinatorial Chemistry +14

AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

Brian Belmontes, Katherine K. Slemmons, Chun Su et al. · Cancer Discovery · 2024 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers

Marc Payton, Brian Belmontes, Kelly Hanestad et al. · Nature Cancer · 2023 · 68 citations · Full text

Life Sciences, Cell Biology, Oncology +17

1–5 of 22